CCP Technologies Ltd (CT1)-医療機器分野:企業M&A・提携分析

◆英語タイトル:CCP Technologies Ltd (CT1) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011467
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CCP Technologies Ltd (CCP), formerly Agenix Ltd is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware and software solutions, that provide critical control point monitoring platforms. The company develops monitoring control points such as temperature and energy consumption drives efficiency and protects the reputation of businesses. Its solutions are used to measure, monitor and report the temperature of fridges in hospitals, grocery stores, food wholesalers, food retailers and major hotels. CCP is headquartered in Melbourne, Victoria, Australia.

CCP Technologies Ltd (CT1) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CCP Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CCP Technologies Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Agenix Enters Into Licensing Agreement With Arrayjet To Develop DiagnostIQ Test 10
Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 11
Equity Offering 12
Agenix Completes Private Placement Of Shares For US$0.78 Million 12
Agenix Completes Rights Offering Of Shares For US$1.3 Million 13
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Debt Offering 16
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 16
CCP Technologies Ltd – Key Competitors 17
CCP Technologies Ltd – Key Employees 18
CCP Technologies Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016 20
Corporate Communications 21
Nov 21, 2016: Agenix: Retirement of Director 21
Oct 18, 2016: Agenix: US sales and key appointment 22
Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors 23
Legal and Regulatory 24
Nov 21, 2016: Agenix: Change of Registered Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
CCP Technologies Ltd, Medical Equipment, Key Facts, 2017 2
CCP Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CCP Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Agenix Enters Into Licensing Agreement With Arrayjet To Develop DiagnostIQ Test 10
Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 11
Agenix Completes Private Placement Of Shares For US$0.78 Million 12
Agenix Completes Rights Offering Of Shares For US$1.3 Million 13
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 16
CCP Technologies Ltd, Key Competitors 17
CCP Technologies Ltd, Key Employees 18

★海外企業調査レポート[CCP Technologies Ltd (CT1)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allinky Biopharma SL:医療機器:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Arcturus Therapeutics Ltd (ARCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcturus Therapeutics Ltd (Arcturus), formerly Alcobra Ltd is a pharmaceutical company that develops a portfolio of nucleic acid therapeutics for treatment of diseases with unmet medical needs. It discovers and develops RNA medicines and design and utilize lipid-mediated drug delivery system …
  • Fairfax Financial Holdings Limited:企業の戦略・SWOT・財務情報
    Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Eneva SA (ENEV3):企業の財務・戦略的SWOT分析
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dassault Systemes SE (DSY):企業の財務・戦略的SWOT分析
    Dassault Systemes SE (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Micro Focus International plc (MCRO):企業の財務・戦略的SWOT分析
    Micro Focus International plc (MCRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ARUP Laboratories-医療機器分野:企業M&A・提携分析
    Summary ARUP Laboratories (ARUP) is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain managemen …
  • Yingli Green Energy Holding Company Limited (YGE):企業の財務・戦略的SWOT分析
    Yingli Green Energy Holding Company Limited (YGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • JFE Holdings, Inc.:戦略・SWOT・企業財務分析
    JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CryoTherapeutics Gmbh-医療機器分野:企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dr. Paul Lohmann GmbH KG:企業の戦略・SWOT・財務情報
    Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AbGenomics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary AbGenomics International Inc (AbGenomics) is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobette …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cardia Inc-医療機器分野:企業M&A・提携分析
    Summary Cardia Inc (Cardia) is a medical device company that designs, manufactures, and markets transcatheter septal occluders for cardiac defect patients. The company’s products include ultrasept ASD, ultraseptLAA, ultraseptPFO, fontan occlude among others. Its UltraseptASD is used for the transven …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Komatsu Ltd (6301):企業の財務・戦略的SWOT分析
    Komatsu Ltd (6301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆